Clinical Trial Update: Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for SYN818 in advanced or metastatic solid tumors; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer
• Prostate Cancer

Drugs mentioned

• SYN818 (SYN818)

Snippet

Sponsor: Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd | Conditions: Advanced Solid Cancer, Metastatic Solid Tumor | Phase 1 | Status: RECRUITING